These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32067865)

  • 1. Platelet aggregation and response to aspirin therapy in cardiac allograft vasculopathy.
    Bjerre KP; Clemmensen TS; Berg K; Poulsen SH; Hvas AM; Grove EL; Løgstrup BB; Jakobsen L; Thim T; Kristensen SD; Eiskjær H
    J Heart Lung Transplant; 2020 Apr; 39(4):371-378. PubMed ID: 32067865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early aspirin use and the development of cardiac allograft vasculopathy.
    Kim M; Bergmark BA; Zelniker TA; Mehra MR; Stewart GC; Page DS; Woodcome EL; Smallwood JA; Gabardi S; Givertz MM
    J Heart Lung Transplant; 2017 Dec; 36(12):1344-1349. PubMed ID: 28781013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Flow Velocity Reserve and Myocardial Deformation Predict Long-Term Outcomes in Heart Transplant Recipients.
    Bjerre KP; Clemmensen TS; Poulsen SH; Hvas AM; Løgstrup BB; Grove EL; Flyvholm F; Kristensen SD; Eiskjær H
    J Am Soc Echocardiogr; 2021 Dec; 34(12):1294-1302. PubMed ID: 34325007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Flow Reserve Predicts Longitudinal Myocardial Deformation Capacity in Heart-Transplanted Patients.
    Clemmensen TS; Løgstrup BB; Eiskjaer H; Poulsen SH
    Echocardiography; 2016 Apr; 33(4):562-71. PubMed ID: 26603966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients: A pediatric heart transplant society analysis.
    D'Addese L; Cantor RS; Koehl D; Reardon L; Ameduri R; Bock M; Morrison A; White S; Wisotzkey B; Kirklin JK; Godown J
    J Heart Lung Transplant; 2023 Jan; 42(1):115-123. PubMed ID: 36328858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of longitudinal myocardial deformation by 2-dimensional speckle-tracking echocardiography in heart transplant recipients: relation to coronary allograft vasculopathy.
    Clemmensen TS; Løgstrup BB; Eiskjær H; Poulsen SH
    J Heart Lung Transplant; 2015 Feb; 34(2):195-203. PubMed ID: 25108908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients.
    Clemmensen TS; Eiskjær H; Løgstrup BB; Ilkjær LB; Poulsen SH
    J Heart Lung Transplant; 2017 May; 36(5):567-576. PubMed ID: 28089194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.
    Tremblay-Gravel M; Racine N; de Denus S; Ducharme A; Pelletier GB; Giraldeau G; Liszkowski M; Parent MC; Carrier M; Fortier A; White M
    JACC Heart Fail; 2017 Dec; 5(12):891-901. PubMed ID: 29191295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up.
    Peled Y; Lavee J; Raichlin E; Katz M; Arad M; Kassif Y; Peled A; Asher E; Elian D; Har-Zahav Y; Shlomo N; Freimark D; Goldenberg I; Klempfner R
    Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 28990263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients.
    Nagumo S; Gallinoro E; Candreva A; Mizukami T; Monizzi G; Kodeboina M; Verstreken S; Dierckx R; Heggermont W; Bartunek J; Goethals M; Buytaert D; De Bruyne B; Sonck J; Collet C; Vanderheyden M
    J Interv Cardiol; 2020; 2020():9835151. PubMed ID: 32733172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cardiac allograft vasculopathy in heart and heart-lung transplantations: a 15-year retrospective study.
    Guihaire J; Mercier O; Flécher E; Aymami M; Fattal S; Chabanne C; Leroy Ladurie F; Lelong B; Cerrina J; Langanay T; Mussot S; Fabre D; De Latour B; Corbineau H; Verhoye JP; Dartevelle P; Leguerrier A; Fadel E
    J Heart Lung Transplant; 2014 Jun; 33(6):636-43. PubMed ID: 24630860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
    Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
    J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
    Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation.
    Bergmark BA; Zelniker TA; Kim M; Mehra MR; Stewart GC; Page DS; Woodcome EL; Givertz MM
    Clin Transplant; 2021 Oct; 35(10):e14424. PubMed ID: 34254366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation.
    Asleh R; Briasoulis A; Smith B; Lopez C; Alnsasra H; Pereira NL; Edwards BS; Clavell AL; Stulak JM; Locker C; Kremers WK; Daly RC; Lerman A; Kushwaha SS
    J Card Fail; 2021 May; 27(5):542-551. PubMed ID: 33962742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients.
    Nelson LM; Rossing K; Ihlemann N; Boesgaard S; Engstrøm T; Gustafsson F
    Clin Transplant; 2020 Dec; 34(12):e14124. PubMed ID: 33068292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific antibodies are associated with micro- and macrovascular coronary disease, restrictive myocardial damage, and poor outcome in heart-transplanted patients.
    Clemmensen TS; Koefoed-Nielsen P; Jensen LA; Poulsen SH; Holm NR; Løgstrup BB; Christiansen EH; Dijkstra J; Valen KPB; Eiskjaer H
    Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28627046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.